Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

PFE 34.28
price chart
Driven By Pfizer Inc. And Novartis AG (ADR), Global Breast Cancer Drug Sales ...
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) accounted for almost 70% of all breast cancer drug sales in 2014, while it is expected that Pfizer Inc. (NYSE:PFE) will be the key growth driver for 24% of sales in 2020 with its star breast cancer drug, Ibrance.
Pfizer Inc. Mega-Merger Talk: The Speculated Targets
Pfizer Inc. (NYSE:PFE) has made it clear that it plans to make a large and strategic acquisition this year. The largest drug maker in the US has developed a reputation for itself, demonstrating time and again that inorganic growth is just as important ...
Speculations at Peak over Pfizer Inc.'s (NYSE:PFE) Potential Targets for ...
Could M&A Boost Pfizer More? Jefferies Thinks So  Benzinga
Pfizer Inc.-GlaxoSmithKline Merger Talk: Deutsche Bank Speculates “PfizerKline”
Rumors have already been crossing wires that Pfizer Inc. (NYSE:PFE) might be interested in a takeover of its UK-based rival GlaxoSmithKline plc (ADR) (NYSE:GSK).
Deutsche Bank claims Pfizer Inc. (NYSE:PFE) Would Benefit From Glaxo Buyout  USMarketsDaily (blog)
How a "PfizerKline" would impact the Triangle  Triangle Business Journal
Trade of the Day: Pfizer (PFE)
Pfizer Inc. (PFE) dropped a bit after lowering its 2015 guidance as part of its latest earnings release on April 28, but it looks like investors are starting to move back into the stock as it bounces up off of the up-trending support level that was ...
Better Dividend Stock: Pfizer, Inc. or GlaxoSmithKline plc?
Dividend stocks are undoubtedly powerful investing vehicles that can greatly amplify gains over a long period of time. That said, it's no easy feat to pick the right dividend stocks for your portfolio.
2 Under-the-Radar Updates Pfizer Inc.'s Shareholders Need to Know About
Pfizer (NYSE: PFE ) is a mind-bogglingly large pharmaceutical company. As such, its quarterly updates tend to focus almost exclusively on high-profile products like the pneumococcal conjugate vaccine Prevnar 13, or clinical candidates such as its ...
Pfizer Inc. To See Boosting Revenues On New Drugs Growth Through 2020
Pfizer Inc. (NYSE:PFE) the world's largest drug manufacturer by sales value, can generate higher long term revenues through the accelerated growth of its new drugs, over the next five years.
All Eyes on Pfizer as Shareholders Await the Mega-Deal: Real M&A
Pfizer Inc. built itself into a $212 billion behemoth by spending more money on acquisitions than any other drugmaker in the world.
Pfizer Inc. (PFE) Rumored To Be Eyeing British Giant GlaxoSmithKline plc (ADR)
Pfizer Inc. (NYSE:PFE) went big exactly a year ago when it announced a takeover offer for UK-based AstraZeneca plc (ADR) (NYSE:AZN).
Will Pfizer Relaunch Its AstraZeneca Bid?  Seeking Alpha
Pfizer Inc. (NYSE:PFE)first quarter earnings results  Inside Trade
Current's Active Movers: Pfizer Inc. (NYSE:PFE), U.S. Bancorp (NYSE:USB ...
On Friday, in the course of current trade, Shares of Pfizer Inc. (NYSE:PFE), dropped -0.09%, and is now trading at $34.33. Pfizer Inc. built itself into a $212 billion behemoth by spending more money on acquisitions than any other drugmaker in the world.